We would like to thank our technician Karolin Thurnes, Divison of Hygiene and Medical Microbiology, and Dr. Annelies M&#252;hlbacher and Dr. Paul H&#246;rtnagl, Central Institute for Blood Transfusion and Immunological Department, for their valuable help and support regarding this manuscript. We thank the Austrian Science Fund for supporting this work (P24598 to DW, P25389 to WP).

Ethics statement: Written informed consent was obtained from all participating blood donors by the Central Institute for Blood Transfusion &#38; Immunological Department, Innsbruck, Austria. The use of anonymized leftover specimens for scientific purposes was approved by the Ethics Committee of the Medical University of Innsbruck.
1. Enrichment of Peripheral Blood Mononuclear Cells (PBMCs)
<ol>
	<li>Concentration of PBMCs by centrifugation.
	<ol>
		<li>Open the blood pack and split blood in ster...

<ol>
	<li>Banchereau, J., Steinman, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dendritic+cells+and+the+control+of+immunity.">Dendritic cells and the control of immunity.</a> Nature. 392, 245-252 (1998).</li><li>Steinman, R. M., Hemmi, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dendritic+cells:+translating+innate+to+adaptive+immunity.">Dendritic cells: translating innate to adaptive immunity.</a> Curr Top Microbiol Immunol. 311, 17-58 (2006).</li><li>Steinman, R. M., Inaba, K., Turley, S., Pierre, P., Mellman, I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antigen+capture,+processing,+and+presentation+by+dendritic+cells:+recent+cell+biological+studies.">Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies.</a> Hum Immunol. 60, 562-567 (1999).</li><li>Schwarz, J., Sixt, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quantitative+Analysis+of+Dendritic+Cell+Haptotaxis.">Quantitative Analysis of Dendritic Cell Haptotaxis.</a> Methods Enzymol. 570, 567-581 (2016).</li><li>Weber, M., Sixt, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Live+cell+imaging+of+chemotactic+dendritic+cell+migration+in+explanted+mouse+ear+preparations.">Live cell imaging of chemotactic dendritic cell migration in explanted mouse ear preparations.</a> Methods Mol Biol. 1013, 215-226 (2013).</li><li>Sixt, M., Lammermann, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vitro+analysis+of+chemotactic+leukocyte+migration+in+3D+environments.">In vitro analysis of chemotactic leukocyte migration in 3D environments.</a> Methods Mol Biol. 769, 149-165 (2011).</li><li>Randolph, G. J., Angeli, V., Swartz, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dendritic-cell+trafficking+to+lymph+nodes+through+lymphatic+vessels.">Dendritic-cell trafficking to lymph nodes through lymphatic vessels.</a> Nat Rev Immunol. 5, 617-628 (2005).</li><li>Wilflingseder, D., Banki, Z., Dierich, M. P., Stoiber, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms+promoting+dendritic+cell-mediated+transmission+of+HIV.">Mechanisms promoting dendritic cell-mediated transmission of HIV.</a> Mol Immunol. 42, 229-237 (2005).</li><li>Pope, M., Gezelter, S., Gallo, N., Hoffman, L., Steinman, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Low+levels+of+HIV-1+infection+in+cutaneous+dendritic+cells+promote+extensive+viral+replication+upon+binding+to+memory+CD4++T+cells.">Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.</a> J Exp Med. 182, 2045-2056 (1995).</li><li>McDonald, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Recruitment+of+HIV+and+its+receptors+to+dendritic+cell-T+cell+junctions.">Recruitment of HIV and its receptors to dendritic cell-T cell junctions.</a> Science. 300, 1295-1297 (2003).</li><li>Pruenster, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=C-type+lectin-independent+interaction+of+complement+opsonized+HIV+with+monocyte-derived+dendritic+cells.">C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.</a> Eur J Immunol. 35, 2691-2698 (2005).</li><li>Wilflingseder, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=IgG+opsonization+of+HIV+impedes+provirus+formation+in+and+infection+of+dendritic+cells+and+subsequent+long-term+transfer+to+T+cells.">IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.</a> J Immunol. 178, 7840-7848 (2007).</li><li>Kapsenberg, M. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dendritic-cell+control+of+pathogen-driven+T-cell+polarization.">Dendritic-cell control of pathogen-driven T-cell polarization.</a> Nat Rev Immunol. 3, 984-993 (2003).</li><li>Mills, K. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=TLR-dependent+T+cell+activation+in+autoimmunity.">TLR-dependent T cell activation in autoimmunity.</a> Nat Rev Immunol. 11, 807-822 (2011).</li><li>Banki, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Complement+as+an+endogenous+adjuvant+for+dendritic+cell-mediated+induction+of+retrovirus-specific+CTLs.">Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.</a> PLoS Pathog. 6, e1000891 (2010).</li><li>Posch, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antibodies+attenuate+the+capacity+of+dendritic+cells+to+stimulate+HIV-specific+cytotoxic+T+lymphocytes.">Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes.</a> J Allergy Clin Immunol. 130, 1368-1374 (2012).</li><li>Posch, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Complement-Opsonized+HIV-1+Overcomes+Restriction+in+Dendritic+Cells.">Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.</a> PLoS Pathog. 11, e1005005 (2015).</li><li>Wilflingseder, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Immediate+T-Helper+17+Polarization+Upon+Triggering+CD11b/c+on+HIV-Exposed+Dendritic+Cells.">Immediate T-Helper 17 Polarization Upon Triggering CD11b/c on HIV-Exposed Dendritic Cells.</a> J Infect Dis. 212, 44-56 (2015).</li><li>Grassi, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Monocyte-derived+dendritic+cells+have+a+phenotype+comparable+to+that+of+dermal+dendritic+cells+and+display+ultrastructural+granules+distinct+from+Birbeck+granules.">Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules.</a> J Leukoc Biol. 64, 484-493 (1998).</li></ol>

This protocol describes the generation of monocyte-derived dendritic cells (MDDCs) through the isolation of human monocytes from anti-coagulated blood using a magnetic nanoparticle-based assay. In this protocol, the centrifugation steps are performed upstream the cell isolation procedure, which leads to an enrichment of the PBMC fraction. Although cells are lost during centrifugation, to overlay the content of a whole blood pack on density gradient medium would require 200-300 ml of the density gradient medium and theref...

Dendritic cells (DCs) are the most important specialized antigen-presenting cells of our immune system. Immature DCs (iDCs) reside in the skin or in mucosal tissues and are therefore among the first immune cells to interact with invading pathogens. DCs represent the bridge between the innate and the adaptive immune system1, since they can activate T- and B-cell responses following pathogen detection. Furthermore, they contribute to pro-inflammatory immune responses because of the secretion of high amounts of cytokines, such as IL-1&#946;, IL-6, and IL-12. DCs also activate NK cells and attract other immune cells to the site of infection by chemotaxis.
DCs can be divided into immature dendritic cells (iDCs) and mature dendritic cells (mDCs)2 based on their morphology and function. After the recognition of foreign antigens by one of the many pattern recognition receptors (e.g., toll-like receptors, C-type lectins, or complement receptors) abundantly expressed on the cell surface, iDCs undergo major changes and start to mature. During this maturation process, receptors for antigen capture are down-regulated, whereas molecules essential for antigen presentation are up-regulated3. Mature DCs up-regulate the major histocompatibility complexes I and II (MHC I and II), co-stimulatory molecules like CD80 and CD86, which are essential for antigen presentation and activation of T-lymphocytes. Additionally, the expression of chemokine receptor CCR7 on the cell surface is induced, which enables the migration of DCs from peripheral tissues to the lymph nodes. The migration is facilitated by the &#34;rolling&#34; of DCs along a chemokine ligand 19 (CCL19/MIP-3b) and chemokine ligand 21 (CCL21/SLC) gradient to the lymph nodes4-6.
Following migration, mDCs present the processed antigen to na&#239;ve CD4+ and CD8+ T cells, thus initiating an adaptive immune response against the invading pathogen7. This interaction with T cells in the lymph nodes is also associated with the spread of the virus8. Other in vitro studies revealed that DCs efficiently capture and transfer HIV to T cells and that this transmission results in a vigorous infection9-12. These experiments highlight that in vivo HIV exploits DCs as shuttles from the periphery to the lymph nodes. During antigen presentation, DCs secrete key interleukins that shape the differentiation of effector T helper cells, and therefore, the outcome of the entire immune response against the microbe is determined at this very interaction. Apart from type 1 (Th1) and type 2 (Th2) effector T cells, other subsets of CD4+ T helper cells (e.g., type 17 (Th17) and type 22 (Th22) T cells) have been described, and their induction and function have been investigated thoroughly. DCs are furthermore involved in the generation of regulatory T cells (Tregs)13,14. These cells are immunosuppressive and can stop or down-regulate induction or proliferation of effector T cells and are thus crucial for developing immunity and tolerance.
Human conventional DCs (cDCs) comprise several subsets of cells with a myeloid origin (i.e., Langerhans Cells (LCs) and dermal and interstitial DCs) or a lymphoid origin (i.e., plasmacytoid DCs (pDCs)). For in vitro experiments or DC vaccination strategies, monocyte-derived DCs are routinely used as a model for dermal DCs. These cells show similarities in physiology, morphology, and function to conventional myeloid dendritic cells. They are generated by the addition of interleukin 4 (IL-4) and granulocyte-macrophage colony-stimulating factor (GM-CSF) to monocytes isolated from healthy donors12,15-18. Dendritic cells can also be directly isolated from dermal or mucosal biopsies, or can even be developed from CD34+ hematopoietic progenitor cells isolated from umbilical cord blood samples obtained ex utero. Here, we demonstrate how monocytes are isolated and stimulated from anti-coagulated human blood after peripheral blood mononuclear cell (PBMC) enrichment by density gradient centrifugation. After incubation for 5 days, human monocytes under specific conditions are differentiated into iDCs and are ready for experimental procedures in a non-clinical setting.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>APC Mouse Anti-Human CD19&#160; Clone&#160; HIB19</td>
			<td>BD Biosciences</td>
			<td>555415</td>
			<td></td>
		</tr>
		<tr>
			<td>APC Mouse Anti-Human CD83&#160; Clone&#160; HB15e</td>
			<td>BD Biosciences</td>
			<td>551073</td>
			<td></td>
		</tr>
		<tr>
			<td>BD Imag Anti-Human CD14 Magnetic Particles&#160;</td>
			<td>BD Biosciences</td>
			<td>557769</td>
			<td></td>
		</tr>
		<tr>
			<td>BD Imagnet</td>
			<td>BD Biosciences</td>
			<td>552311</td>
			<td></td>
		</tr>
		<tr>
			<td>BSA (Albumin Fraction V)</td>
			<td>Carl Roth</td>
			<td>EG-Nr 2923225</td>
			<td></td>
		</tr>
		<tr>
			<td>Costar 6 Well Clear TC-Treated Multiple Well Plates</td>
			<td>Costar</td>
			<td>3506</td>
			<td></td>
		</tr>
		<tr>
			<td>Density gradient media: Ficoll-Paque Premium</td>
			<td>GE Healthcare Bio-Sciences</td>
			<td>17-5442-03</td>
			<td></td>
		</tr>
		<tr>
			<td>Dulbecco&#8217;s Phosphate Buffered Saline (D-PBS)</td>
			<td>Sigma-Aldrich</td>
			<td>D8537</td>
			<td></td>
		</tr>
		<tr>
			<td>Falcon 10mL Serological Pipet</td>
			<td>Corning</td>
			<td>357551</td>
			<td></td>
		</tr>
		<tr>
			<td>Falcon 25mL Serological Pipet</td>
			<td>Corning</td>
			<td>357525</td>
			<td></td>
		</tr>
		<tr>
			<td>Falcon 50mL High Clarity PP Centrifuge Tube</td>
			<td>Corning</td>
			<td>352070</td>
			<td></td>
		</tr>
		<tr>
			<td>Falcon Round-Bottom Tubes</td>
			<td>Corning</td>
			<td>352054</td>
			<td></td>
		</tr>
		<tr>
			<td>FITC Mouse Anti-Human CD3&#160; Clone&#160; HIT3a</td>
			<td>BD Biosciences</td>
			<td>555339</td>
			<td></td>
		</tr>
		<tr>
			<td>Ghost Dye Violet 510 (Cell Viability Reagent)</td>
			<td>Tonbo biosciences</td>
			<td>13-0870</td>
			<td></td>
		</tr>
		<tr>
			<td>GM-CSF</td>
			<td>MACS Miltenyi Biotec</td>
			<td>130-093-862</td>
			<td></td>
		</tr>
		<tr>
			<td>Heat Inactivated FBS (Fetal Bovine Serum), EU Approved Origin (South America)</td>
			<td>Gibco</td>
			<td>10500-064</td>
			<td></td>
		</tr>
		<tr>
			<td>Hettich Rotanta 460R</td>
			<td>Hettich</td>
			<td>---</td>
			<td></td>
		</tr>
		<tr>
			<td>IL-4 CC</td>
			<td>PromoKine</td>
			<td>C-61401</td>
			<td></td>
		</tr>
		<tr>
			<td>Isolation buffer: BD IMag Buffer (10X)&#160;</td>
			<td>BD Biosciences</td>
			<td>552362</td>
			<td></td>
		</tr>
		<tr>
			<td>L-Glutamine solution</td>
			<td>Sigma-Aldrich</td>
			<td>G7513</td>
			<td></td>
		</tr>
		<tr>
			<td>Microcentrifuge tubes, 1,5 ml, SuperSpin</td>
			<td>VWR</td>
			<td>211-0015</td>
			<td></td>
		</tr>
		<tr>
			<td>PE Mouse Anti-Human CD14&#160; Clone&#160; M5E2</td>
			<td>BD Biosciences</td>
			<td>555398</td>
			<td></td>
		</tr>
		<tr>
			<td>PE Mouse Anti-Human CD209&#160; Clone&#160; DCN46</td>
			<td>BD Biosciences</td>
			<td>551265</td>
			<td></td>
		</tr>
		<tr>
			<td>RPMI-1640 medium</td>
			<td>Sigma-Aldrich</td>
			<td>R0883</td>
			<td></td>
		</tr>
		<tr>
			<td>UltraPure 0.5M EDTA, pH 8.0</td>
			<td>Invitrogen</td>
			<td>15575020</td>
			<td></td>
		</tr>
	</tbody>
</table>

generation of human monocyte-derived dendritic cells from whole blood

Dendritic cells (DCs) recognize foreign structures of different pathogens, such as viruses, bacteria, and fungi, via a variety of pattern recognition receptors (PRRs) expressed on their cell surface and thereby activate and regulate immunity. 
The major function of DCs is the induction of adaptive immunity in the lymph nodes by presenting antigens via MHC I and MHC II molecules to na&#239;ve T lymphocytes. Therefore, DCs have to migrate from the periphery to the lymph nodes after the recognition of pathogens at the sites of infection. For in vitro experiments or DC vaccination strategies, monocyte-derived DCs are routinely used. These cells show similarities in physiology, morphology, and function to conventional myeloid dendritic cells. They are generated by interleukin 4 (IL-4) and granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation of monocytes isolated from healthy donors. Here, we demonstrate how monocytes are isolated and stimulated from anti-coagulated human blood after peripheral blood mononuclear cell (PBMC) enrichment by density gradient centrifugation. Human monocytes are differentiated into immature DCs and are ready for experimental procedures in a non-clinical setting after 5 days of incubation.

After centrifugation of anti-coagulated blood using a sucrose cushion, peripheral blood mononuclear cells (PBMCs) are enriched in an interphase on top of the density gradient medium (Figure 1). After the PBMCs are drawn off, FACS analysis is performed to characterize the different cell populations within the PBMCs using lineage markers (e.g., CD3 for T lymphocytes, CD14 for monocytes, and CD19 for B lymphocytes). Figure 2A shows the results of a ...

Watch this Scientific Journal Video about Generation of Human Monocyte-derived Dendritic Cells from Whole Blood at JoVE.com

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Here, we demonstrate how monocytes are isolated by magnetic bead separation from peripheral blood mononuclear cells after density gradient centrifugation of human anti-coagulated blood. Following incubation for 5 days, human monocytes are differentiated into immature dendritic cells and are ready for experimental procedures in a non-clinical setting.

Dendritic cells (DCs) recognize foreign structures of different pathogens, such as viruses, bacteria, and fungi, via a variety of pattern recognition ...

The overall goal of this CD14 magnetic beads separation technique is to isolate monocytes from the blood for their further differentiation into dendritic cells or macrophages in vitro. This method can help answer key questions in the field of immunology about the recognition, processing, and presentation of pathogens or antigens by dendritic cells. The main advantage of this isolation procedure is that the 98 to 99%pure monocyte population can be obtained.Demonstrating the procedure will be Karolin Thurnes, a technician from our work group. Begin by splitting the blood pack volume among sterile 50 milliliter centrifuge tubes according to the amount of blood received. Adjust the final volume in each tube to 50 milliliters with sterile Dulbecco's PBS as necessary and centrifuge the samples.Using a sterile one milliliter serological pipette connected to a laboratory vacuum pump, remove the plasma and platelet layers leaving the boundary layers undisturbed. Then, use a new 25 milliliter pipette to combine the mononuclear cell boundary layers from two of the tubes in the new sterile 50 milliliter conical tube. Next, add 15 milliliters of density gradient medium to each of 450 milliliter conical tubes and pipetting slowly and carefully, overlay 25 milliliters of pooled blood cells onto the density gradient in each tube.Separate the cells by centrifugation. Then aspirate the plasma and platelet upper layers and transfer the PBMC interphases into new individual 50 milliliter conical tubes. Wash the PBMCs two times with up to 50 milliliters of sterile DPBS, pulling the cells after the first centrifugation and resuspending the pellet in 50 milliliters of fresh DPBS after the second.After counting, collect the cells by centrifugation for monocyte magnetic particle isolation. To purify the monocytes by magnetic particle isolation, adjust the PBMC concentration to eight times 10 to the 7th cells per milliliter of isolation buffer. Next, vortex the anti-human CD14 magnetic particles thoroughly and mix 50 microliters of particles for every one times 10 to the 7th PBMCs into the cells, and transfer the cell bead solution to a sterile 15 milliliter tube.After 30 minutes at room temperature, adjust the total volume to 12 milliliters of isolation buffer, and transfer two milliliters of the cell particle suspension into each of six sterile round bottom tubes. Immediately place the tubes onto the cell separation magnet for 10 minutes at room temperature. Then remove the supernatant containing the peripheral blood lymphocytes from each tube.Remove the tubes from the magnet and add two milliliters of fresh isolation buffer to each cell sample. Gently pipette up and down to resuspend the cells and particles, and return the tubes to the magnet for another five minutes. At the end of the incubation, remove the supernatant again, and resuspend the cells in two milliliters of fresh isolation buffer as just demonstrated.Then pull the CD14 positive monocyte containing cell fractions into a new 50 milliliter tube and bring the final volume of the tube up to 50 milliliters in sterile DPBS. To differentiate the purified monocytes into dendritic cells, collect the cells by centrifugaiton and resuspend the pellet in 50 milliliters of DPBS. After counting, spin down the cells again and resuspend the pellet at a one times 10 to the 6th cells per milliliter concentration and prewarmed culture medium.Transfer three milliliters of cells into each well of a six well plate and add recombinant human Interleukin four and GMCSF to each well for a 48 hour incubation at 37 degrees Celsius and 5%carbon dioxide. On the second day of culture, restimulate the cells with fresh cytokines and return the plate to the incubator. On day five, pull the supernatants and gently pipette fresh medium into the wells several times to harvest the immature dendritic cells.After density gradient separation, a typical PBMC fraction is comprised of about 4%B-lymphocytes, 28%monocytes and 68%other cells. 44%of which are t-lymphocytes. After magnetic particle separation, flow cytometric analysis of the negative fraction reveals a similar percentage of b-lymphocytes, a higher percentage of the other cell populations and a greatly reduced percentage of monocytes.Characterization of the positive fraction demonstrates the high purificaiton efficiency with over 99%of the cells expressing CD14. After five days of Interleukin four and GMCSF simulation, the CD14 positive cells differentiate into immature CD83 negative DC-SIGN positive monocyte derived dendritic cells which are comparable to dermal dendritic cells in the morphology, behavior, and receptor expression. Once mastered, this technique can be completed in four to five hours if it is performed properly.After watching this video, you should have a good understading of how to isolate monocytes from whole blood and differentiate them into dendritic cells. This technique is very important for researchers in the field of immunology to explore not only dendritic cell, but also monocyte and macrophage function in the primary in vitro human cell system. Following this procedure, other methods like microscopic analysis, flow cytometry, infection or antigen presentation essays can be performed to answer questions about dendritic cell biology, function and interactions with antigens.Don't forget that working with blood can be hazardous and that precautions such as wearing gloves, a lab coat or having a hepatitis vaccination should always be taken before beginning this procedure.

generation-of-human-monocyte-derived-dendritic-cells-from-whole-blood

Research

JoVE Journal

Immunology and Infection

20.0K visualizações.  Medical University of Innsbruck. The overall goal of this CD14 magnetic beads separation technique is to isolate monocytes from the blood for their further differentiation into dendritic cells or macrophages in vitro. This method can help answer key questions in the field of immunology about the recognition, processing, and presentation of pathogens or antigens by dendritic cells. The main advantage of this isolation procedure is that the 98 to 99%pure monocyte population can be obtained.Demonstrating the procedure wi...